What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Management

First-Line Treatment: Benzathine Penicillin G

Parenteral penicillin G is the only proven effective treatment for all stages of syphilis, with specific dosing determined by disease stage. 1, 2

Primary and Secondary Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single dose is the definitive treatment 1, 2, 3
  • This regimen applies to both primary chancres and secondary manifestations (rash, mucocutaneous lesions, lymphadenopathy) 4
  • Treatment success is verified by a fourfold decline in nontreponemal titers within 6 months 1, 2

Early Latent Syphilis

  • Same regimen as primary/secondary: Benzathine penicillin G 2.4 million units IM single dose 1, 2
  • Early latent is defined as infection acquired within the preceding year based on documented seroconversion, fourfold titer increase, symptom history, or partner with documented early syphilis 2

Late Latent, Latent of Unknown Duration, and Tertiary Syphilis

  • Benzathine penicillin G 7.2 million units total: three doses of 2.4 million units IM given at weekly intervals 1, 2, 3
  • If a dose is missed, an interval of 10-14 days between doses is acceptable before restarting the sequence 2
  • This extended regimen is necessary because late-stage disease requires prolonged treponemacidal levels 5

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units daily, administered as 3-4 million units IV every 4 hours for 10-14 days 3
  • CSF examination is mandatory before diagnosing neurosyphilis in patients with neurological signs/symptoms, tertiary syphilis, or treatment failure 2, 3

Alternative Treatment for Penicillin-Allergic Patients

Non-Pregnant Adults Only

  • Primary/secondary syphilis: Doxycycline 100 mg orally twice daily for 14 days 1, 2, 3
  • Late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days 1, 2

Critical Caveat: Pregnant Women and Neurosyphilis

  • Penicillin is the ONLY proven effective therapy for preventing maternal-fetal transmission and treating neurosyphilis 1, 2
  • All pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment 6, 1, 2
  • Erythromycin and tetracyclines are contraindicated—erythromycin cannot reliably cure fetal infection, and tetracyclines are teratogenic 6
  • Skin testing may help confirm true penicillin allergy before desensitization 6, 7

Special Populations

HIV-Infected Patients

  • Use the same treatment regimens as non-HIV-infected patients 1, 2
  • HIV patients may have atypical serologic responses but generally respond well to standard penicillin therapy 2
  • For late latent syphilis with HIV and normal CSF: benzathine penicillin G 7.2 million units (three weekly doses of 2.4 million units each) 6
  • All syphilis patients should be tested for HIV 6, 3

Pregnant Women

  • Screen all pregnant women for syphilis at first prenatal visit, during third trimester, and at delivery 6, 4
  • Treat with the penicillin regimen appropriate for disease stage 6, 3
  • Some experts recommend an additional dose of benzathine penicillin 2.4 million units IM one week after initial treatment for women in third trimester or with secondary syphilis 6
  • Warning: Jarisch-Herxheimer reaction during second half of pregnancy may precipitate premature labor or fetal distress 6
  • Women should seek immediate medical attention if they notice changes in fetal movements or contractions after treatment 6

Pediatric Patients

  • Children with acquired primary/secondary syphilis: Benzathine penicillin G 50,000 units/kg IM, up to adult dose of 2.4 million units single dose 1
  • Newborns have incompletely developed renal function that may delay penicillin elimination, requiring dosage adjustments 7

Follow-Up and Monitoring

Serologic Monitoring

  • Repeat quantitative nontreponemal tests (RPR or VDRL) at 6,12, and 24 months 1, 2, 3
  • Expected response: fourfold decline in titer within 6 months for primary/secondary syphilis 1, 2, 3
  • For late syphilis, expect fourfold decline within 12-24 months 1

Treatment Failure Criteria

  • Failure of nontreponemal titers to decline fourfold within 6 months after therapy for primary/secondary syphilis 1, 2, 3
  • Fourfold increase in titers at any point 1
  • Development of neurological signs or symptoms 1

Management of Treatment Failure

  • Re-treat with weekly injections of benzathine penicillin G 2.4 million units IM for 3 weeks 1
  • Perform CSF examination to rule out neurosyphilis 1, 2
  • Re-evaluate for HIV infection 2

Management of Sex Partners

Recent Exposure (≤90 Days)

  • Treat presumptively with benzathine penicillin G 2.4 million units IM single dose, even if seronegative 1, 2
  • This applies to partners of patients with primary, secondary, or early latent syphilis 1, 2

Exposure >90 Days

  • Treat presumptively if serologic results are not immediately available and follow-up is uncertain 2
  • Otherwise, evaluate clinically and serologically before deciding on treatment 1

Long-Term Partners of Late Syphilis

  • Evaluate clinically and serologically rather than treating presumptively 1

Critical Pitfalls to Avoid

Medication Errors

  • Never use oral penicillin preparations—they are completely ineffective for syphilis 2
  • Do not substitute different penicillin formulations; benzathine penicillin G provides the prolonged treponemacidal levels required 1, 2

Monitoring Errors

  • Do not switch between different nontreponemal tests (VDRL vs RPR) when monitoring response—results cannot be directly compared 2
  • Do not use treponemal test titers (FTA-ABS, MHA-TP) to assess treatment response—they correlate poorly with disease activity and often remain positive for life 2
  • A fourfold change means a two-dilution change (e.g., 1:32 to 1:8), not a simple multiplication 3

Drug Interactions

  • Avoid concurrent use of bacteriostatic antibiotics (tetracyclines, erythromycins, chloramphenicol, sulfonamides) with penicillin—they may antagonize penicillin's bactericidal effect 7
  • Probenecid, aspirin, phenylbutazone, sulfonamides, indomethacin, and thiazide diuretics prolong penicillin half-life by competing for renal tubular secretion 7

Jarisch-Herxheimer Reaction

  • Inform all patients about this acute febrile reaction that may occur within 24 hours of treatment, especially in early syphilis 2
  • Symptoms include fever, headache, myalgia, and temporary worsening of skin lesions 2
  • This is not an allergic reaction and does not contraindicate future penicillin use 2

Addressing Benzathine Penicillin G Shortages

When benzathine penicillin G is unavailable:

  • For non-pregnant adults with early syphilis: doxycycline 100 mg orally twice daily for 14 days is acceptable 1, 8
  • For pregnant women: exhaust all efforts to locate benzathine penicillin G, including contacting multiple facilities and pharmacies 8
  • Contact local health departments and CDC for assistance in locating supply 8
  • Never substitute with inadequate alternatives in pregnancy—only penicillin prevents congenital syphilis 6, 1

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.